Your browser doesn't support javascript.
loading
Hepatitis B virus infection and the risk of cancer among the Chinese population.
Tian, Ting; Song, Ci; Jiang, Longfeng; Dai, Jingjing; Lin, Yuan; Xu, Xin; Yu, Chengxiao; Ge, Zijun; Ding, Yuqing; Wen, Yang; Liu, Bo; Shao, Yuyun; Shi, Ping; Zhu, Chuanlong; Liu, Yuan; Jing, Shenqi; Wang, Zhongmin; Hu, Zhibin; Li, Jun.
Afiliação
  • Tian T; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Song C; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China.
  • Jiang L; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Dai J; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China.
  • Lin Y; Department of Microbiology and Immunology, Nanjing Medical University, Nanjing, China.
  • Xu X; Department of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Yu C; Department of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Ge Z; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Ding Y; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China.
  • Wen Y; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Liu B; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China.
  • Shao Y; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Shi P; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China.
  • Zhu C; Office of Infection Management, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Liu Y; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Jing S; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China.
  • Wang Z; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Hu Z; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China.
  • Li J; Department of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Int J Cancer ; 147(11): 3075-3084, 2020 12 01.
Article em En | MEDLINE | ID: mdl-32478856
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B / Antígenos de Superfície da Hepatite B / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B / Antígenos de Superfície da Hepatite B / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article